In conclusion, we show that for AD the optimal p-value threshold is pT ≤ 0.1, and the PRS calculation should account for the age-related genetic differences in cases and controls either by modelling APOE separately to the PRS or by matching cases and controls for age and APOE status. This evidence concerns the gene APOE and Alzheimer disease.